Ozempic is nearly identical to the hormone GLP-1, but slight molecular differences make it more effective at aiding in sustainable weight loss
British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, and Atlantic provinces generally cover GLP-1 medications only for diabetes indications
Complete the CWMP certification assessment
Cardiovascular and renal benefits have been consistently demonstrated, with lower rates of cardiovascular events observed in semaglutide-treated patients compared with placebo
The Journal of Sports Medicine and Physical Fitness
25,26 However, these studies were criticized for small sample size, the short-term duration of the studies, the fact the studies showed correlation not causation, and the studies used higher dosages that are not typical of everyday use